The Company entered into a Placement Agency Agreement with D. Boral Capital LLC (the “Placement Agent”), dated May 15, 2026, pursuant to which the Placement Agent acted as the exclusive placement age…
ion, NanoViricides will pay 15 % of net sales to TheraCour, as defined in the agreement. On March 27, 2023 the Company entered into a license agreement with KMPL wherein the Company granted to KMPL…
NanoViricides, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
NNVC-DEBT-11327
Warrants outstanding: 347222
90%
xbrl warrant detail from xbrl 2020-01-27.
NNVC-DEBT-11328
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2024-06-30.
NanoViricides, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for NanoViricides, Inc..
NanoViricides, Inc. Ownership
Holder
Name
Confidence
Evidence
NNVC-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC
VANGUARD CAPITAL MANAGEMENT LLC
90%
13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 49 tracked holders.